February 26, 2016—The Centers for Medicare & Medicaid Services has sent state Medicaid agencies guidance on how to implement new final regulations governing Medicaid reimbursement for covered outpatient drugs, including those bought through the 340B drug discount program. … [Read more...]
House Appropriations Chairman Slams 340B User Fee Again
Proposal "chips away at the sustainability" of rural hospitalsFebruary 25, 2016—House Appropriations Chairman Hal Rogers (R-Ky.) has again criticized the Obama administration's proposal to begin financing the 340B program through user fees on drug purchases. … [Read more...]
Pedley Cites Benefits of 340B Regulatory Authority
Requirements could be more specific with binding rulesFebruary 23, 2016—Congress would strengthen the Health Resources and Services Administration's hand in managing the 340B drug discount program if it gave it HRSA clear authority to issue binding and enforceable 340B regulations, the head HRSA's Office of Pharmacy Affairs says. … [Read more...]
Georgia Medicaid Postpones New 340B Claims Identification Policy
Was due to take effect April 1February 12, 2016—The Georgia Department of Community Health (DCH) has postponed implementation of a new policy for 340B claims identification. … [Read more...]
Amgen Providing 340B Refunds on Most of Its Products
Price restatements include Enbrel, Neulasta, and ProliaFebruary 12, 2016—Amgen, the world's largest biotechnology company by revenue, is giving 340B covered entities refunds stemming from "an adjustment of its 340B ceiling price" on nine of its 16 products, including its blockbusters Enbrel, Neulasta, and Prolia. … [Read more...]
Study: Medicare Pays 340B Hospitals Less for Part B Drugs
DSH hospitals also treat more vulnerable patients than other providersFebruary 11, 2016—Medicare pays disproportionate share hospitals in the 340B drug discount program 13 percent less on average for separately payable drugs reimbursed through Medicare Part B than it pays other hospitals and physician practices in the Part B market, researchers have found. The new study also shows that 340B DSH hospitals are treating more vulnerable patients than … [Read more...]
340B Recertification for Most Federal Grantees Rescheduled for Feb. 12
Process was originally set to start Jan. 27February 10, 2016—Annual recertification of eligibility for most federal grantees in the 340B drug discount program will begin Friday Feb. 12, and end Wednesday March 9, the Health Resources and Services Administration announced today. … [Read more...]